Effective Mrna Inhibition in PANC-1 Cells in Vitro Mediated Via an Mpeg-Sese-pei Delivery System.
Yuefeng Zhang,Bin Yang,Yajie Liu,Wenjie Qin,Chao Li,Lantian Wang,Wen Zheng,Yulian Wu
DOI: https://doi.org/10.1248/bpb.b15-00645
2016-01-01
Biological and Pharmaceutical Bulletin
Abstract:RNA interference (RNAi)-mediated gene therapy is a promising approach to cure various diseases. However, developing an effective, safe, specific RNAi delivery system remains a major challenge. In this study, a novel redox-responsive polyetherimide (PEI)-based nanovector, mPEG-SeSe-PEI, was developed and its efficacy evaluated. We prepared three mPEG-SeSe-PEI vector candidates for small interfering glyceraldehyde-3-phosphate dehydrogenase (siGADPH) and determined their physiochemical properties and transfection efficiency using flow cytometry and PEG11.6-SeSe-PEI polymer. We investigated the silencing efficacy of GADPH mRNA expression in PANC-1 cells and observed that PEG11.6-SeSe-PEI/siGADPH (N/P ratio=10) polyplexes possessed the appropriate size and zeta-potential and exhibited excellent in vitro gene silencing effects with the least cytotoxicity in PANC-1 cells. In conclusion, we present PEG11.6-SeSe-PEI as a potential therapeutic gene delivery system for small interfering RNA (siRNA).
What problem does this paper attempt to address?